Latest From Jinghong Chen
With Reform Efforts Persisting, PBM Trade Association Sets Lobbying Record
Infographic details who gave what to whom as all segments of the US healthcare industry gear up for the presidential election cycle.
Time To Tip the Scales? Humira Biosimilars And The Limitations Of Competition In US Health Care
In year two, Humira biosimilar uptake – or the lack thereof – continues to build the case for policy reform to incentivize use of cheaper biologics in the outpatient setting.
Pharma Spent Record Amount on Lobbying in 2022
Our infographic breaks down the biggest contributors, recipients and legislative targets.